Martin MacKay

Martin MacKay has an estimated net worth of $31.1 Million. This is based on reported shares across multiple companies, which include PFIZER INC, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., Rallybio Corp, 5:01 Acquisition Corp., ALEXION PHARMACEUTICALS INC, ENCYSIVE PHARMACEUTICALS INC, SpringWorks Therapeutics, Inc., and Kailera Therapeutics, Inc..

2009 was Martin MacKay's most active year for acquiring shares with 25 total transactions. Martin MacKay's most active month to acquire stocks was the month of April. 2016 was Martin MacKay's most active year for disposing of shares, totalling 10 transactions. Martin MacKay's most active month to dispose stocks was the month of January. 2013 saw Martin MacKay paying a total of $10,486,000.00 for 125,000 shares, this is the most they've acquired in one year. In 2015 Martin MacKay cashed out on 95,323 shares for a total of $15,610,885.87, their largest year based on trade value.